FIELD: biotechnology.
SUBSTANCE: group of inventions is described, including a method for selective hydrolysis of S-enantiomer of alpha-haloalkanoic acid (options). In one of options, the method includes stages of provision of racemate of R-enantiomer and S-enantiomer of alpha-haloalkanoic acid, provision of polypeptide having dehalogenase activity with an amino acid sequence SEQ ID NO. 1, and reaction of selective hydrolysis of racemate for 4-6 hours. The method provides obtainment of excess of R-enantiomer from 90.0 to 99.9%, after 4-6 hours.
EFFECT: invention expands the arsenal of methods for selective hydrolysis of S-enantiomers of alpha-haloalkanoic acids.
5 cl, 5 dwg, 3 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
T-CELL RECEPTOR CONSTRUCTS AND THEIR USE | 2019 |
|
RU2785954C2 |
MUTANT OF PHOSPHOLIPASE WITH HIGH ENZYMATIC ACTIVITY | 2019 |
|
RU2818353C2 |
RECOMBINANT CELLS PRODUCING HYALURONIC ACID | 2022 |
|
RU2839983C2 |
ANTIBODIES B7-H4 AND METHODS FOR THEIR APPLICATION | 2019 |
|
RU2809243C2 |
METHODS FOR PRODUCING PROTEOLYTICALLY PROCESSED POLYPEPTIDES | 2019 |
|
RU2727402C1 |
RECOMBINANT PRODUCTION OF STEVIOL GLYCOSIDES | 2014 |
|
RU2741103C2 |
INSECTICIDAL PROTEINS AND THEIR APPLICATION METHODS | 2015 |
|
RU2747978C2 |
TNF-α BINDING POLYPEPTIDE AND METHOD FOR TREATMENT OF TNF-α RELATED DISEASES | 2017 |
|
RU2794974C2 |
METHODS FOR PRODUCING PROTEOLYTICALLY PROCESSED POLYPEPTIDES | 2018 |
|
RU2719164C1 |
DNA ANTIBODY CONSTRUCTIONS FOR USE AGAINST LYME DISEASE | 2017 |
|
RU2813829C2 |
Authors
Dates
2023-02-21—Published
2018-09-24—Filed